{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:17:48Z","timestamp":1770275868883,"version":"3.49.0"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T00:00:00Z","timestamp":1334793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002<\/jats:bold>Holtze M, Mickien\u00e9 A, Atlas A, Lindquist L, Schwieler L (Karolinska Institutet, Stockholm; Lithuanian University of Health Sciences, Kaunas, Lithuanian; Karolinska Institutet, Karolinska University Hospital, Huddinge; Karolinska Institutet, Karolinska University Hospital, Solna, Sweden). Elevated cerebrospinal fluid kynurenic acid levels in patients with tick\u2010borne encephalitis.<jats:italic>J Intern Med<\/jats:italic>2012; 272: 394\u2013401.<\/jats:p><jats:p><jats:bold>Background.\u2002<\/jats:bold>Kynurenic acid (KYNA) is a neuroactive metabolite of tryptophan that is thought to regulate cognitive functions. Previous studies have shown that levels of KYNA increase during virus infection and that this metabolite interacts with the immune system.<\/jats:p><jats:p><jats:bold>Objective.\u2002<\/jats:bold>The aim of the study was to investigate whether patients with tick\u2010borne encephalitis (TBE), a viral infectious disease associated with long\u2010term cognitive impairment, have increased levels of KYNA in the cerebrospinal fluid (CSF).<\/jats:p><jats:p><jats:bold>Methods.\u2002<\/jats:bold>CSF KYNA was analysed using high\u2010performance liquid chromatography in 108 patients with TBE and 52 age\u2010matched controls. Patients were classified according to the severity of TBE: mild (47%), moderate (44%) or severe (9%).<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold>Concentrations of CSF KYNA were considerably higher in patients with TBE (5.3\u2003nmol\u2003L<jats:sup>\u22121<\/jats:sup>) than in control subjects (0.99\u2003nmol\u2003L<jats:sup>\u22121<\/jats:sup>). KYNA concentration in the CSF varied greatly amongst individuals with TBE and increased (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.05) with the severity of disease.<\/jats:p><jats:p><jats:bold>Conclusions.\u2002<\/jats:bold>This is the first study to demonstrate increased levels of CSF KYNA in patients with TBE. The importance of brain KYNA in both immune modulation and neurotransmission raises the possibility that abnormal levels of the compound in TBE might play a part in the pathophysiology of the disease. A detailed knowledge of endogenous brain KYNA during the course of CNS infection might yield further insights into the neuroimmunological role of the compound and may also provide new pharmacological approaches for the treatment of cognitive symptoms.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2012.02539.x","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T12:43:06Z","timestamp":1332592986000},"page":"394-401","source":"Crossref","is-referenced-by-count":31,"title":["Elevated cerebrospinal fluid kynurenic acid levels in patients with tick\u2010borne encephalitis"],"prefix":"10.1111","volume":"272","author":[{"given":"M.","family":"Holtze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mickien\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Schwieler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2010.10.007"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.11.2067"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/342059"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549609027160"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00811-3"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03434.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.11.023"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.010058-0"},{"key":"e_1_2_7_10_2","first-page":"182","article-title":"Apoptosis as a mechanism for the cytopathic action of tick\u2010borne encephalitis virus","volume":"43","author":"Isaeva MP","year":"1998","journal-title":"Vopr Virusol"},{"key":"e_1_2_7_11_2","first-page":"54","article-title":"The morphological characteristics of cell death in different forms of acute tick\u2010borne encephalitis","volume":"114","author":"Kamalov NI","year":"1998","journal-title":"Morfologiia"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280600848746"},{"key":"e_1_2_7_13_2","first-page":"199","article-title":"Specific induction of pulmonary indoleamine 2,3\u2010dioxygenase by bacterial lipopolysaccharide","volume":"65","author":"Hayaishi O","year":"1978","journal-title":"Ciba Found Symp"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.06.013"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90367-6"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb01881.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0022-3565(24)37160-5","article-title":"Novel systemically active antagonists of the glycine site of the N\u2010methyl\u2010D\u2010aspartate receptor: electrophysiological, biochemical and behavioral characterization","volume":"283","author":"Parsons CG","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0164-7"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.01.009"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923020-00001"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2006.02.005"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)02242-X"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01078-2"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050149"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21799"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.127"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.39"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbq002"},{"key":"e_1_2_7_30_2","first-page":"448","article-title":"ELISA for IgM and IgG antibodies against tick\u2010borne encephalitis virus: quantification and standardization of results","volume":"255","author":"Hofmann H","year":"1983","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.07.013"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)82308-7"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(90)90309-W"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.3.908"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-011-0681-y"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020121"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.02.005"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:BEBM.0000024388.49008.ab"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4260"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/64.6.506"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2010.05.010"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-011-0605-2"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq024"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603503200"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.11.014"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2008.10.005"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp074"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb03460.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020472"},{"key":"e_1_2_7_51_2","first-page":"109","article-title":"Interferon gamma concentration in the cerebrospinal fluid of patients with tick\u2010borne encephalitis","volume":"39","author":"Kondrusik M","year":"2005","journal-title":"Neurol Neurochir Pol"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4101-07.2007"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1997.17.589"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1159\/000086295"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.090180"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20241"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009383"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbl033"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300188"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.006"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.5.1249"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283437f9a"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2012.02539.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2012.02539.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T23:13:08Z","timestamp":1742771588000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2012.02539.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,19]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1365-2796.2012.02539.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02539.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,19]]}}}